BioEye
BioEye (branded BrainEye) is a Sydney-based digital health company that offers a smartphone app using eye-tracking computer vision to deliver 60-second brain health assessments, serving consumers, sporting organizations for concussion screening, and medical research centers.
- Company typePrivate
- Founded2017
- HeadquartersSydney, Australia
- Headcount11–50
- GTM typeB2C
- OfferingSoftware
What BioEye does
BioEye, legally registered as BRAINEYE and operating under the consumer-facing brand BrainEye, is a Sydney-based digital health company founded in 2017 that has built a smartphone-based brain health monitoring application. The company's core technology uses smartphone cameras to capture and analyze eye responses to visual stimuli, producing a 60-second test that returns real-time results indicating whether the user falls within a normal range or whether follow-up steps are recommended. The underlying eye-tracking pipeline is described as computer-vision-based and has been validated against scientific-grade eye trackers and clinical trials, with independent research oversight provided by the Monash University Neuroscience Department.
The company serves three distinct customer segments: sporting codes and athletes requiring regular concussion screening, medical centers and clinical research institutions interested in deploying the BioEye technology platform for research, and general consumers seeking at-home brain health monitoring. Distribution is product-led through the Apple App Store and Google Play Store, enabling global reach without physical infrastructure. Monetization mechanics are not publicly disclosed—pricing is not listed on the website and no revenue figures or funding rounds have been disclosed—suggesting the business is at an early commercialization stage. The company also markets a brand ambassador relationship with World Cup-winning French footballer Emmanuel Petit and operates a research-collaboration motion targeting sporting bodies for concussion studies.
Strategic positioning emphasizes accessibility (smartphone-native, no clinical visit required), speed (60-second test), affordability, and third-party-validated accuracy. The leadership team comprises CEO Marcus Schweizer and Founder/CTO Dovi Yellin, supported by an in-house team of experts across technology, business, and medicine. Headcount is reported in the 11–50 range, no institutional investors or parent entities have been disclosed, and the corporate website copyright extends through 2026, indicating ongoing operations.
BioEye firmographics
Firmographics- Name
- BioEye
- Legal name
- BRAINEYE
- Website
- https://bioeye.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BioEye (branded BrainEye) is a Sydney-based digital health company that offers a smartphone app using eye-tracking computer vision to deliver 60-second brain health assessments, serving consumers, sporting organizations for concussion screening, and medical research centers.
- Ownership category
- akta.pro rank
BioEye industry classification
Industry- Product category
- Digital Brain Health Monitoring
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industries
- Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices) (CRACAQAL), Neurology Telemedicine Platforms (HLALAGAC)
Keywords
Where BioEye is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Markets served
BioEye business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
BioEye product offering
Product offeringCore offering
BioEye (operating as BrainEye) sells a smartphone application that uses the device's camera and proprietary eye-tracking technology to measure a user's eye responses to visual stimuli in 60 seconds. The app delivers a real-time brain health assessment, indicating whether the user's results fall in a normal range or whether next steps are recommended. The BioEye technology platform is also made available through research collaborations with sporting codes and medical centres for concussion studies.
Product overview
BrainEye is a single unified mobile application for consumer brain health monitoring. The BrainEye App is the core product—a smartphone-based solution that uses eye-tracking technology to measure eye responses to visual stimuli, delivering real-time brain health assessments in 60 seconds. The technology is also available through research and clinical partnerships (BioEye platform) for concussion trials and medical center research programs. The product portfolio consists of the consumer-facing BrainEye mobile app (iOS and Android) as the primary offering, with the BioEye technology platform being used in academic research settings such as Monash University Neuroscience Department concussion studies.
Differentiator
Problem solved
Functional benefit
Products and services
- BrainEye App
Quantifiable outcome
- Test results delivered in 60 seconds
Companies that use BioEye
Customer profileSegments3 records
Ideal customer profiles3 records
BioEye technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature1 record
BioEye partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- Monash University Neuroscience DepartmentcoreMonash University Neuroscience Department oversees independent research for BioEye concussion trials. Sporting codes are invited to participate in BioEye concussion research studies under this independent academic oversight, providing credibility and scientific rigor to the validation process.
- Emmanuel PetitminorWorld Cup champion French footballer serves as BrainEye Brand Ambassador. His global recognition and personal commitment bring credibility and passion to the mission of revolutionising brain health. His advocacy helps connect with a wider audience and spreads awareness about brain health management.
Scale indicators1 record
Recent moves6 records
Expansion highlights4 records
BioEye competitors and assessment
Company assessmentEmerging players
- Altoida: Altoida is a digital biomarker company using smartphone-based AR and AI for cognitive and neurological assessment. Comparable overlap in leveraging consumer devices and AI for brain health diagnostics.
- Akili Interactive: Akili Interactive creates FDA-cleared digital therapeutics for cognitive dysfunction delivered via consumer devices. Comparable as a digital brain-health company leveraging consumer technology platforms.
Direct peers
- SyncThink: SyncThink provides eye-tracking-based concussion and balance assessment tools (e.g., EYE-SYNC) used by US military, NCAA, and clinical partners. Directly comparable as a neuro-assessment technology company targeting concussion screening via ocular metrics.
- RightEye: RightEye builds eye-tracking assessments for neurological and developmental conditions using standard cameras. Comparable as an eye-tracking neuro-assessment platform with consumer/clinical crossover.
- Oculogica: Oculogica develops the EyeBOX neuro-diagnostic, an FDA-cleared eye-tracking test for concussion. Most directly comparable as an eye-tracking-based brain health diagnostic company addressing concussion assessment.
- Sway Medical: Sway Medical offers FDA-cleared mobile concussion assessment through smartphone-based balance and reaction tests. Closely comparable as a smartphone-based brain/concussion assessment tool serving sports and clinical use cases.
- King-Devick Technologies: King-Devick provides tablet-based rapid sideline concussion screening via eye movement testing. Comparable as a tablet/eye-movement-based concussion screening tool adopted by professional sports organizations.
Broad incumbents
- Cambridge Cognition: Cambridge Cognition offers validated digital cognitive assessment tools used in clinical trials and healthcare. Comparable as a digital neuro/cognitive assessment provider with clinical research positioning.
- BrainScope: BrainScope develops FDA-cleared EEG-based devices for head injury assessment. Compares as a brain-injury diagnostic company pursuing clinical-grade regulatory approvals.
- Cogstate: Cogstate provides computerized cognitive testing widely used in concussion research and elite sports (e.g., NFL, Premier League). Comparable as a digital brain-performance assessment company with strong sports/clinical credibility.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
BioEye social profiles
Digital presenceBioEye financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioEye leadership team
Management profileNumber of profiles
Profiles2 records
BioEye funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioEye M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioEye
What does BioEye do?
BioEye (operating as BrainEye) sells a smartphone application that uses the device's camera and proprietary eye-tracking technology to measure a user's eye responses to visual stimuli in 60 seconds. The app delivers a real-time brain health assessment, indicating whether the user's results fall in a normal range or whether next steps are recommended. The BioEye technology platform is also made available through research collaborations with sporting codes and medical centres for concussion studies.
Is BioEye a public or private company?
BioEye is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BioEye founded?
BioEye was founded in 2017. It employs 11 to 50 people.
Where is BioEye based?
BioEye is headquartered in Sydney, Australia, in the Oceania region.
Who are BioEye's main competitors?
Emerging players on record are Altoida and Akili Interactive. Direct peers are SyncThink, RightEye, Oculogica, Sway Medical and King-Devick Technologies. Broad incumbents are Cambridge Cognition, BrainScope and Cogstate.
Does BioEye have an API?
No public API is recorded for BioEye.
What industry is BioEye in?
BioEye's product category is Digital Brain Health Monitoring. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of CRACAQAL, Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices). Its NAICS code is 334510 and its SIC code is 3845.